Condition: Scoliosis Neuromuscular · Scoliosis Idiopathic · Consent Forms · Sponsor: EUROS
The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children. As part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino. Retrospective and prospective multicenter post-market surveillance clinical study. This study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children. The secondary objective of this clinical study is to monitor the performance of the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children. The study will include 140 patients.
This description comes directly from the study's public registry record.
Célia Armanet, PHD · +330756848896 · carmanet@euros.fr
Always discuss trial participation with your own doctor first.
| Hopital Lenval Nice | Nice, Provence-Alpes-Côte d'Azur Region, France | Recruiting |
| CHU Pellegrin | Bordeaux, France | Recruiting |
| Hospices Civils de Lyon | Lyon, France | Not Yet Recruiting |
| Hopital Armand Trousseau | Paris, France | Not Yet Recruiting |
| Hopital Necker | Paris, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07403084